Can methicillin‑sensitive Staphylococcus aureus (MSSA) cause fluid‑filled blisters in wound infections without the methicillin‑resistance (MRSA) gene?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, methicillin-sensitive Staphylococcus aureus (MSSA) can absolutely cause fluid-filled blisters in wound infections

Both MSSA and MRSA are capable of producing the same spectrum of skin and soft tissue infections, including bullous (blister-forming) lesions, because the methicillin resistance gene (mecA) only confers antibiotic resistance—it does not determine virulence or clinical presentation.

Understanding the Clinical Presentation

The ability of S. aureus to cause fluid-filled blisters depends on virulence factors, not methicillin resistance status. Key points:

  • Panton-Valentine leukocidin (PVL) and other toxins like exfoliative toxins determine whether S. aureus causes purulent, necrotizing, or bullous lesions 1, 2
  • Research demonstrates that PVL-positive MSSA strains are genetically similar to MRSA strains (particularly USA300-related clones) and cause identical clinical presentations including abscesses and purulent infections 1
  • Studies show MSSA and MRSA have no significant difference in wound morbidity or clinical presentation—only in antibiotic susceptibility 3

Specific Blister-Forming Scenarios

MSSA commonly causes fluid-filled blisters in:

  1. Bullous impetigo: Caused by exfoliative toxin-producing S. aureus (typically MSSA)
  2. Wound infections with abscess formation: Both MSSA and MRSA create purulent collections 4, 5
  3. Secondary infection of existing wounds: MSSA accounts for significant wound infections with various presentations 2, 5

Research from wound infections shows MSSA isolates frequently carry virulence genes (sea, icaA, hla) that contribute to tissue damage and fluid accumulation 2. A 5-fold increase in MSSA abscess cultures paralleled the MRSA epidemic, with PVL-positive MSSA causing pus-forming lesions indistinguishable from MRSA infections 1.

Treatment Implications

The presence of blisters or purulent drainage does NOT indicate MRSA—culture and susceptibility testing are essential 6, 7. For empiric treatment:

  • Mild infections: Dicloxacillin, cephalexin, or clindamycin cover MSSA effectively 7
  • If MRSA suspected: Add TMP-SMX, doxycycline, or vancomycin pending cultures 6, 8
  • Incision and drainage remains primary treatment for abscesses regardless of methicillin susceptibility 6, 7

Critical Pitfall

Do not assume fluid-filled blisters or purulent infections automatically mean MRSA. Studies show 65.4% of wound S. aureus may be MRSA, but 31.9% are MSSA with identical clinical presentations 5. The clinical appearance cannot distinguish between them—always obtain cultures from purulent lesions to guide definitive therapy 6, 7.

References

Research

contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009

Related Questions

What broad-spectrum antibiotic regimen provides coverage for methicillin-sensitive Staphylococcus aureus (MSSA)?
In a 1‑month‑old infant with methicillin‑sensitive Staphylococcus aureus (MSSA) abscesses of the arm and leg and negative chronic granulomatous disease (CGD) testing, and no scheduled follow‑up with pediatric infectious disease (Peds ID), should the child be referred to additional specialists?
Is methicillin‑resistant Staphylococcus aureus (MRSA) that is tetracycline‑sensitive also susceptible to doxycycline?
What is the appropriate management, including antibiotic selection, source control, and treatment duration, for methicillin‑susceptible Staphylococcus aureus (MSSA) bacteremia in an adult with end‑stage renal disease on dialysis who has a tunneled catheter and a pleural effusion?
How should glomerulonephritis be treated in a 13-year-old patient?
What is the appropriate evaluation and management for increased hip abduction in an infant or young child?
What is the appropriate evaluation and management for an elderly patient who develops new or worsening weakness after right hip surgery?
What are the typical symptoms of a grade 1 (mild) diffuse axonal injury?
In a patient on chronic warfarin (target INR 2.0‑3.0) scheduled for an elective percutaneous coronary intervention (PCI), what is the recommended management of warfarin, bridging anticoagulation, and antiplatelet therapy before, during, and after the procedure?
What is the appropriate treatment for acute gout in a 70-year-old male with involvement of the left great toe?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.